
Overview
Background
Emeritus Professor Maree Smith AC FTSE FAHMS is a full-time researcher and Director, CIPDD, School of Biomedical Sciences, Faculty of Medicine, The University of Queensland.
In the 12 years prior to her current appointment, Professor Smith led a high-performing team in building the CIPDD and its commercial interface TetraQ, recognized as a unique, GLP-accredited drug development Centre in Australia. Professor Smith has considerable expertise in biomedical discovery/translation with specialist expertise in the novel pain therapeutics discovery/translation field encompassing a portfolio of 16 rodent pain models that mimic individual human pain conditions. This portfolio of models conducted in a purpose-built facility operated in accordance with the requirements of our Quality Management System, making the CIPDD unique in Australia and rare internationally.
In the 15 years prior to establishing the CIPDD, Professor Maree Smith was a full-time academic in the School of Pharmacy. In brief, she joined the School of Pharmacy as a Lecturer in 1989 and was successively promoted through the academic ranks to Professor in 2004. Prior to that she undertook a PhD and early postdoctoral training in clinical pharmacology with specialist expertise in bioanalytical method development, bioanalysis of human plasma samples, drug metabolism and clinical pharmacokinetics. Her second postdoc was in the field of pain management and pain pharmacology.
In the years, 1990-2005, Maree Smith taught in the Drug Discovery stream of the 2nd, 3rd & 4th years of the undergraduate Pharmacy program and she was instrumental in developing innovative courses for the final year of the undergraduate Pharmacy curriculum. She was also instrumental in the development of a course for the M Biotech program at UQ entitled “Quality Systems in Biotechnology” which continues to this day and is a compulsory course in the Program. Maree has successfully advised/co-advised to completion 33 PhD students, 2 Research Masters students and ~50 Honours students. She also served for 14 years as an external evaluator for the TGA.
Maree's Current Research Interests are as follows:
1. Subtle differences in the pathobiology of individual chronic pain conditions
2. Improving preclinical to clinical translation in novel analgesics development
3. Preclinical drug development of novel pain therapeutics
4. Preclinical drug development
Awards
2021 UQ Fellowship
2019 Companion of the Order of Australia (AC) in the Queen's Birthday Honours List
2018 Honorary Bragg Membership (The Royal Institution of Australia)
2016 Bowl of Hygeia Award (Pharmaceutical Society of Australia)
2016 Clunies Ross Knowledge Commercialisation Award (ATSE)
2015 Honoured to be included in inaugural list of Australia's top Innovators; viz Knowledge Nation 100
2015 Inaugural Inductee into the Life Sciences Queensland (LSQ) Hall of Fame
2015 Johnson and Johnson Innovaton AusBiotech Industry Excellen Award - Outstanding Leader category.
2015 Elected Fellow, Australian Academy of Health and Medical Sciences (AAHMS)
2015 Australian Pain Society Distinguished Member Award - For services to the promotion, treatment and science of pain management and lifelong contribution to the Australian Pain Society
2013 UQ Top 5 Inventor - Award by Thomson Reuters and UQ at inaugural Awards
2013 UQ Top 5 Innovator - Award by UniQuest Pty Ltd and UQ at inaugural Awards
2012 Queensland Life Sciences Industry Excellence Award jointly with Dr Jim Aylward
2011 Elected Fellow, Australian Academy of Technological Sciences (ATSE)
2009 Honorary Fellowship, Faculty of Pain Medicine, ANZCA (Australian and New Zealand College of Anaesthetists).
2008 WiT (Women in Technology): Biotech Outstanding Achievement Award
2002 Meritorious Mention for Sustained Excellence in Research Higher Degree Supervision
2001 Meritorious Mention for Sustained Excellence in Research Higher Degree Supervision
Availability
- Emeritus Professor Maree Smith is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor (Honours), The University of Queensland
- Doctor of Philosophy, The University of Queensland
Research impacts
Maree is a leading researcher internationally in the pain field. Spinifex Pharmaceuticals was formed in 2005 to commercialize her angiotensin II type 2 (AT2) receptor antagonists technology for neuropathic pain and subsequently chronic inflammatory pain. Spinifex was acquired by Novartis in mid-2015 on the basis of successful early phase clinical trials in patients with post-herpetic neuralgia, a type of peripheral neuropathic pain that is often intractable.
Also, she has highly specialized expertise in the pain field encompassing a portfolio of 15 innovative rodent pain models that closely mimic individual human pain conditions. These models combined with the OECD GLP accreditation of the CIPDD facility means that these capabilities are unique in Australia and rare outside of large pharmaceutical companies internationally.
Works
Search Professor Maree Smith’s works on UQ eSpace
2009
Conference Publication
DEVELOPMENT OF XEN2174: NON-CLINICAL STUDIES AND AN OPEN-LABEL I/IIa STUDY OF INTRATHECAL USE IN ONCOLOGY PATIENTS WITH MODERATE TO SEVERE PAIN
Martin, W., Lewis, R. J., Palant, E., Brust, A., Colless, B., Schmidt, P., Drinkwater, R., Stearns, L. J., Cousins, M., Gouke, R., Hughes, D., Rauck, R., Day, D., Nielsen, C. K. and Smith, M. T. (2009). DEVELOPMENT OF XEN2174: NON-CLINICAL STUDIES AND AN OPEN-LABEL I/IIa STUDY OF INTRATHECAL USE IN ONCOLOGY PATIENTS WITH MODERATE TO SEVERE PAIN. 21st American Peptide Symposium, Bloomington in, Jun 07-12, 2009. HOBOKEN: JOHN WILEY & SONS INC.
2009
Conference Publication
Development of XEN2174 and an escalating safety and tolerability study of intrathecal use in oncology patients
Brust, A., Colless, B., Cousins, M., Day, D., Drinkwater, R., Gouke, R., Hughes, D., Lewis, R. J., Martin, W., Nielson, C., Palant, E., Rauck, R., Schmidt, P., Smith, M. T. and Steams, L. J. (2009). Development of XEN2174 and an escalating safety and tolerability study of intrathecal use in oncology patients. Michal Lebl Peptides Breaking Away, Bloomington, Indiana, U.S.A., 7-12 June, 2009. San Diego, C.A. U.S.A.: American Peptide Society.
2009
Journal Article
Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-dawley rats: Differences between the tail flick and hot plate nociceptive tests
South, Samantha M., Edwards, Stephen R. and Smith, Maree T. (2009). Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-dawley rats: Differences between the tail flick and hot plate nociceptive tests. Clinical and Experimental Pharmacology and Physiology, 36 (1), 20-28. doi: 10.1111/j.1440-1681.2008.05019.x
2009
Conference Publication
High-quality, cost-effective preclinical product development solutions
Smith, Maree (2009). High-quality, cost-effective preclinical product development solutions. BIO Korea 2009, Seoul, Korea, 16-18 September 2009. Seoul, Korea: BIO Korea 2009.
2009
Conference Publication
A study of the application of the Morris water maze to the establishment of a preclinical model of Alzheimer's disease in the rat
Edwards, Stephen and Smith, M.T. (2009). A study of the application of the Morris water maze to the establishment of a preclinical model of Alzheimer's disease in the rat. ASCEPT 43rd Annual Scientific Meeting 2009: The Rights of Medicines, Darling Harbour, NSW, Australia, 29 November-2 December 2009.
2009
Journal Article
Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A (2-17) following spinal and supraspinal routes of administration
Hemstapat, K., Le, L., Edwards, S. R. and Smith, M. T. (2009). Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A (2-17) following spinal and supraspinal routes of administration. Pharmacology, Biochemistry and Behaviour, 93 (4), 498-505. doi: 10.1016/j.pbb.2009.06.016
2008
Journal Article
Differences between and combinations of opiods re-visited
Smith, Maree T. (2008). Differences between and combinations of opiods re-visited. Current Opinion in Anaesthesiology, 21 (5), 596-601. doi: 10.1097/ACO.0b013e32830a4c4a
2008
Other Outputs
Pain-relieving compositions and uses therefore
Smith, M. T. (2008). Pain-relieving compositions and uses therefore. PCT/AU2008/000003: WO/2008/080194.
2008
Journal Article
An update on the pharmcological management of post-herpetic neuralgia and painful diabetic neuropathy
Zin, Che S., Nissen, Lisa M., Smith, Maree T., O'Callaghan, James P. and Moore, Brendan J. (2008). An update on the pharmcological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs, 22 (5), 417-442. doi: 10.2165/00023210-200822050-00005
2008
Journal Article
Sex differences in the pharmacokinetics, oxidative metabolism and oral bioactivity of oxycodone in the sprague-dawley rat
Chan, S., Edwards, S. R., Wyse, B. D. and Smith, M. T. (2008). Sex differences in the pharmacokinetics, oxidative metabolism and oral bioactivity of oxycodone in the sprague-dawley rat. Clinical and Experimental Pharmacology and Physiology, 35 (3), 295-302. doi: 10.1111/j.1440-1681.2007.04821.x
2008
Conference Publication
Mechanistic insight into the anti-allodynic effects of PRG100
Huang, L., Smith, M. T. and Wyse, B. D. (2008). Mechanistic insight into the anti-allodynic effects of PRG100. 12th World Congress on Pain, Glasgow, Scotland, U. K., 17-22 August 2008. IASP Press.
2008
Conference Publication
Taking the pain out of research
Smith, M. T., Williamson, O. and Farrell, M. (2008). Taking the pain out of research. 28th Annual Scientific Meeting of the Australian Pain Society, Perth, Australia, 30 March - 2 April, 2008.
2008
Conference Publication
Influence of diet on the longitudinal temporal development of opioid hyposensitivity and tactile allodynia in the Zucker Diabetic Fatty (ZDF) rat
Cabot, P.J., Otto, K., Smith, M.T., South, S.M. and Wyse, B.D. (2008). Influence of diet on the longitudinal temporal development of opioid hyposensitivity and tactile allodynia in the Zucker Diabetic Fatty (ZDF) rat. 28th Annual Scientific Meeting of the Australian Pain Society: The Spectrum of Pain, Perth, Australia, 30 March – 2 April, 2008.
2008
Book Chapter
Pain pharmacology and analgesia
Smith, Maree T. and South, Samantha M. (2008). Pain pharmacology and analgesia. Encyclopedia of Life Support Systems. (pp. 1-80) edited by H. Majewski. Oxford, U.K.: EOLSS Publishers.
2008
Conference Publication
Novel strategies in new opioid analgesic development
Smith, M. T. (2008). Novel strategies in new opioid analgesic development. Combined CME Spring Meeting of Faculty of Pain Medicine, ANZCA, Acute Pain special Interest Group of ANZCA, ASA and NZSA, Acute Pain Special Interest Group of IASP, Ayers Rock, Northern Territory, Australia, 18-20 September 2008.
2008
Conference Publication
Mechanistic insight into the anti-allodynic effects of PRG150
Huang, L., Wyse, B. D. and Smith, M. T. (2008). Mechanistic insight into the anti-allodynic effects of PRG150. 12th World Congress on Pain, Glasgow, Scotland, 17-22 August 2008.
2008
Conference Publication
Comparative profiles of the antinociceptive and constipating effects of single intracerebroventricular (i.c.v.) bolus doses of morphine, morphine-6-glucuronide and fentanyl in rats Kuo A, Hemstapat K, Wyse BD, Smith MT
Hemstapat, K., Kuo, A., Smith, M.T. and Wyse, B.D. (2008). Comparative profiles of the antinociceptive and constipating effects of single intracerebroventricular (i.c.v.) bolus doses of morphine, morphine-6-glucuronide and fentanyl in rats Kuo A, Hemstapat K, Wyse BD, Smith MT. 4th Scientific Meeting of the Australian Health and Medical Research Congress, Brisbane, Australia, 16 - 21 November, 2008.
2008
Conference Publication
Development of novel X-conopeptide inhibitors of the norepinephrine transporter with analgesic potential
Lewis, R. J., Palant, E., Brust, A., Colless, B., Schmidt, P., Nielsen, C. K., Smith, M. T. and Drinkwater, R. (2008). Development of novel X-conopeptide inhibitors of the norepinephrine transporter with analgesic potential. 12th World Congress on Pain, Glasgow, Scotland, 17-22 August, 2008.
2008
Conference Publication
Preclinical development of new drugs for pain treatment
Smith, M. T. (2008). Preclinical development of new drugs for pain treatment. 4th Australian Health and Medical Research Congress, Brisbane, Australia, 16-21 November 2008. Brisbane, Australia:
2008
Conference Publication
Influence of diet on the longitudinal temporal development of opioid hyposensitivity and tactile allodynia in the Zucker Diabetic Fatty (ZDF) rat
Otto, K., Wyse, B. D., South, S. M., Cabot, P. J. and Smith, M. T. (2008). Influence of diet on the longitudinal temporal development of opioid hyposensitivity and tactile allodynia in the Zucker Diabetic Fatty (ZDF) rat. 12th World Congress on Pain, Glasgow, Scotland, 17-22 August 2008.
Funding
Current funding
Past funding
Supervision
Availability
- Emeritus Professor Maree Smith is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Pathobiology of Neuropathic (nerve damage) Pain
-
Novel neuropathic pain therapeutics discovery
-
Painful Diabetic Neuropathy: Towards Improved Drug Treatments
Supervision history
Current supervision
-
Doctor Philosophy
Discovery and Pharmacological Evaluation of Novel Analgesics for the Relief of Ross River Virus Induced Chronic Pain
Principal Advisor
Other advisors: Professor Kate Schroder, Dr Andy Kuo, Dr Mohammad Zafar Imam
-
Doctor Philosophy
Novel long-acting and orally delivered conotoxin-based peptides with both analgesic efficacy and disease modifying potential
Principal Advisor
Other advisors: Associate Professor Richard Clark, Dr Andy Kuo
-
Doctor Philosophy
Discovery and development of an Antibiotic Modulator to Break Antibiotic Resistance in a Mouse Infection Model
Principal Advisor
Other advisors: Professor Mark Walker, Dr Andy Kuo, Dr David De Oliveira
-
Doctor Philosophy
Understanding the role acid-sensing ion channels in disease progression and pain associated with neuroinflammatory conditions.
Associate Advisor
Other advisors: Dr Neville Butcher, Dr Nemat Khan, Dr Lachlan Rash
-
Doctor Philosophy
A novel treatment for chronic pain
Associate Advisor
Other advisors: Professor Trent Woodruff, Dr Andy Kuo, Dr Amanda Kijas, Dr Felicity Han
-
Doctor Philosophy
Breaking antibiotic resistance in multi-drug resistant Acinetobacter baumanni
Associate Advisor
Other advisors: Dr David De Oliveira, Professor Mark Walker
Completed supervision
-
2020
Doctor Philosophy
Novel prolonged-release polymeric particles for relief of intractable neuropathic pain
Principal Advisor
Other advisors: Professor Andrew Whittaker, Dr Felicity Han
-
2019
Doctor Philosophy
Insight into the Pathobiology of Breast Cancer Induced Bone Pain in a Rat Model
Principal Advisor
Other advisors: Dr Nemat Khan
-
2019
Doctor Philosophy
Analgesic efficacy of novel opioid compounds relative to adverse effects in rats
Principal Advisor
Other advisors: Dr Andy Kuo
-
2019
Doctor Philosophy
Chronic low back pain: pathobiological investigations towards improved treatments
Principal Advisor
Other advisors: Dr Andy Kuo
-
2015
Doctor Philosophy
Cellular and molecular insights into multiple sclerosis-induced neuropathic pain
Principal Advisor
Other advisors: Professor Trent Woodruff
-
2015
Doctor Philosophy
Cancer Chemotherapy Induced Peripheral Neuropathy (CIPN): Preclinical Studies
Principal Advisor
Other advisors: Professor Kristofer Thurecht, Professor Andrew Whittaker
-
2014
Doctor Philosophy
Establishment, optimisation and pharmacological characterisation of rat model of postherpetic neuralgia pain with varicella zoster virus
Principal Advisor
-
2013
Doctor Philosophy
PATHOPHYSIOLOGICAL MECHANISMS CONTRIBUTING TO PROSTATE CANCER-INDUCED BONE PAIN
Principal Advisor
-
2013
Doctor Philosophy
Systematic evaluation of in vitro and in vivo opioid profiling
Principal Advisor
-
2011
Doctor Philosophy
Utilisation of nitric oxide donors for the relief of mechanical allodynia in a rat model of painful diabetic neuropathy
Principal Advisor
-
2009
Doctor Philosophy
Painful diabetic neuropathy: preclinical studies to improve therapeutic insight
Principal Advisor
Other advisors: Professor Peter Cabot
-
2008
Doctor Philosophy
Preclinical Studies in Painful Diabetic Neuropathy
Principal Advisor
Other advisors: Professor Gregory Monteith, Professor Peter Cabot
-
2005
Master Philosophy
PHARMACOKINETIC-PHARMACODYNAMIC MODELLING OF ANTI-ALLODYNIC EFFECTS OF GABAPENTIN AND OXYCODONE IN A RODENT MODEL OF PERSISTENT NERUOPATHIC PAIN
Principal Advisor
-
2003
Doctor Philosophy
Studies investigating (i) The development of antinociceptive tolerance to oxycodone and cross-tolerance with morphine in rats (ii) Elucidation of opioid receptors mediating oxycodone's antinociception using radioligand binding and (iii)antiallodynia of oxycodone and morphine in a rat model of neuropathic pain
Principal Advisor
-
2003
Doctor Philosophy
NEUROPHARMACOLOGY OF MORPHINE-3-glucuronide (M3G)
Principal Advisor
Other advisors: Professor Gregory Monteith
-
2023
Doctor Philosophy
Analgesic Drug Discovery
Associate Advisor
Other advisors: Professor Craig Williams
-
2019
Doctor Philosophy
Advanced Diffusion Magnetic Resonance Imaging at Ultrahigh Field to Investigate Neurological Microstructural Changes in an EAE Mouse Model of Multiple Sclerosis
Associate Advisor
Other advisors: Dr Nyoman Kurniawan
-
2019
Doctor Philosophy
Bioanalytical method development and validation to investigate cytochrome P450 mediated drug metabolism in patients receiving extracorporeal life support.
Associate Advisor
Other advisors: Professor Kiran Shekar
-
2018
Doctor Philosophy
Establishment, optimization and characterization of a rat model of breast cancer induced bone pain
Associate Advisor
Other advisors: Dr Andy Kuo, Professor Irina Vetter
-
2015
Doctor Philosophy
Skin sensitisation prediction using in vitro screening methods
Associate Advisor
-
2015
Doctor Philosophy
Development of magnetic resonance diffusion weighted imaging at 16.4T to assess neurological degeneration in a mouse model of multiple sclerosis
Associate Advisor
Other advisors: Dr Nyoman Kurniawan
-
2012
Doctor Philosophy
"Phantom Skin Pain" - Neuropathic Pain Following Burn Injury: An Examination of Incidence and Treatment
Associate Advisor
Other advisors: Professor Peter Cabot, Professor Jeffrey Lipman
-
2009
Doctor Philosophy
Assessment of Fucoidin efficacy in A-peptide induced Alzheimer¿s disease rodent model
Associate Advisor
Other advisors: Professor Peter Cabot
-
2002
Doctor Philosophy
QUALITY USE OF MEDICINES: FROM DUE TO RURAL COMMUNITY PHARMACY PRACTICE
Associate Advisor
Other advisors: Emeritus Professor Sue Tett
Media
Enquiries
Contact Emeritus Professor Maree Smith directly for media enquiries about:
- Bioanalysis - drugs
- Clinical trials - drug development
- Drug analysis
- Drug development
- Efficacy models - pharmacology
- Opioid pharmacology
- Pain management - pharmacy
- Pharmacokinetics
- Pharmacology
- Pharmacy
- Preclinical drug development
- Preclinical efficacy models
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: